Oren Pasvolsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MD Anderson Research Highlights for January 25, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.

United statesLauren byersSimon heekeMuzaffar qazilbashDavids hongJohn heymachKonstantin sokolovXiaoxi panKevan morrisOren pasvolskyAaron schwartz duvalVinay pattalachintiMichiaki itoRugang zhangJohn paul shenMolecular cancer research

MD Anderson Unveils Key Research Highlights for Jan 25, 2024

MD Anderson Unveils Key Research Highlights for Jan 25, 2024
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesLauren byersSimon heekeMuzaffar qazilbashDavids hongJohn heymachKonstantin sokolovXiaoxi panKevan morrisOren pasvolskyVinay pattalachintiAaron schwartz duvalMichiaki itoRugang zhangJohn paul shenNational cancer institute

MD Anderson Research Highlights for January 25, 2024

MD Anderson Research Highlights for January 25, 2024
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

United statesJohn paul shenMichiaki itoRugang zhangVinay pattalachintiAaron schwartz duvalKevan morrisOren pasvolskyXiaoxi panJohn heymachKonstantin sokolovDavids hongLauren byersSimon heekeMuzaffar qazilbashMolecular cancer research

Younger patients with multiple myeloma can achieve durable survival

Younger patients with multiple myeloma can achieve durable survival
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomOren pasvolskyUniversity of texas md anderson cancer centerMd anderson cancer centerBritish journalCancer center

Daratumumab Maintenance Is Safe, Feasible After Salvage Transplant in Multiple Myeloma

Daratumumab maintenance therapy with or without pomalidomide provided a tolerable and feasible treatment option after salvage hematopoietic stem cell transplantation in patients with relapsed multiple myeloma.

United statesDaratumumab darzalexOren pasvolskyUniversity of texas md anderson cancer centerDepartment of stem cell transplantationCellular therapyCancer centerBased maintenance